4.5 Article

Divergent developmental expression and function of the proton-coupled oligopeptide transporters PepT2 and PhT1 in regional brain slices of mouse and rat

Journal

JOURNAL OF NEUROCHEMISTRY
Volume 129, Issue 6, Pages 955-965

Publisher

WILEY-BLACKWELL
DOI: 10.1111/jnc.12687

Keywords

brain; development; expression; function; PepT2; PhT1

Funding

  1. National Institutes of Health National Institute of General Medical Sciences [R01-GM035498]
  2. National Institute of Neurological Disorders and Stroke [R01-NS037409]

Ask authors/readers for more resources

This study evaluated the developmental gene and protein expression of proton-coupled oligopeptide transporters (POTs: peptide transporter, PepT1 and PepT2; peptide-histidine transporter, PhT1 and PhT2) in different regions of rodent brain, and the age-dependent uptake of a POT substrate, glycylsarcosine (GlySar), in brain slices. Slices were obtained from cerebral cortex, cerebellum and hippocampus of wildtype and PepT2 null mice, and from rats at different ages. Gene and protein expression were determined by real-time PCR and immunoblot analyses. Brain slice uptakes of radiolabeled glycylsarcosine were determined in the absence and presence of excess unlabeled glycylsarcosine or l-histidine, the latter being an inhibitor of PhT1/2 but not PepT1/2. As PepT2 and PhT1 transcripts were abundantly expressed in all three regions of mouse brain, little to no expression was observed for PepT1 and PhT2. PhT1 protein was present in brain regions of adult but not neonatal mice and expression levels increased with age in rats. Glycylsarcosine uptake, inhibition and transporter dominance did not show regional brain or species differences. However, there were clear age-related differences in functional activity, with PepT2 dominating in neonatal mice and rats, and PhT1 dominating in adult rodents. These developmental changes may markedly impact the neural activity of both endogenous and exogenous (drug) peptides/mimetics. Developmental gene and protein expression of peptide transporters was evaluated in various regions of rodent brain, along with age-dependent uptake of dipeptide. We found marked changes in protein expression and functional activity of PhT1 and PepT2, the former predominating in adult and the latter in neonate. These developmental changes may markedly impact the neural activity of endogenous and exogenous peptides/mimetics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Clinical Neurology

Too big, too small: selecting hematoma sizes for inclusion in intracerebral hemorrhage-deferoxamine trials

Fenghui Ye, Yingfeng Wan, Sravanthi Koduri, Katherine G. Holste, Richard F. Keep, Ya Hua, Guohua Xi

TRANSLATIONAL STROKE RESEARCH (2023)

Article Clinical Neurology

Iron-Induced Hydrocephalus: the Role of Choroid Plexus Stromal Macrophages

Chaoyi Bian, Yingfeng Wan, Sravanthi Koduri, Ya Hua, Richard F. Keep, Guohua Xi

Summary: This study found that intraventricular iron injection in rats led to hydrocephalus and increased stromal macrophage number. Treatment with minocycline or clodronate liposomes improved iron-induced hydrocephalus and reduced the increase in stromal macrophages.

TRANSLATIONAL STROKE RESEARCH (2023)

Article Neurosciences

Brain edema formation and therapy after intracerebral hemorrhage

Yingfeng Wan, Katherine G. Holste, Ya Hua, Richard F. Keep, Guohua Xi

Summary: Intracerebral hemorrhage (ICH) is responsible for 10% of strokes in the USA, resulting in significant disability and mortality. It causes primary brain injury due to mechanical disruption and secondary injury through the release of clot-derived factors. ICH leads to brain edema and increased intracranial pressure, affecting patient prognosis. Currently, effective treatment methods for reducing perihematomal cerebral edema and intracranial pressure are limited. This review explores the mechanisms of edema formation, the influence of sex and age, and the progress in pharmacotherapy for ICH.

NEUROBIOLOGY OF DISEASE (2023)

Article Endocrinology & Metabolism

Characteristics of activation of monocyte-derived macrophages versus microglia after mouse experimental intracerebral hemorrhage

Fenghui Ye, Jinting Yang, Katherine G. Holste, Sravanthi Koduri, Ya Hua, Richard F. Keep, Hugh J. L. Garton, Guohua Xi

Summary: Both monocyte-derived macrophages (MDMs) and brain resident microglia contribute to hematoma resolution after intracerebral hemorrhage (ICH). In this study, transgenic mice with enhanced green fluorescent protein (EGFP) labeled microglia were used to observe changes in MDMs and microglia after ICH. The results showed that MDMs entered the brain and formed a peri-hematoma cell layer by day 3 after ICH, and CD47 blocking antibody increased the number of MDMs around and inside the hematoma. These findings suggest that MDMs play an important role in phagocytosis after ICH and modulation of MDMs could be a potential therapeutic target.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2023)

Editorial Material Neurosciences

Fluid movement in the healthy and diseased brain

Yejie Shi, Richard F. Keep

NEUROBIOLOGY OF DISEASE (2023)

Review Chemistry, Multidisciplinary

Proton-Coupled Oligopeptide Transport (Slc15) in the Brain: Past and Future Research

Jianming Xiang, Richard F. Keep

Summary: This mini-review provides an overview of the role of the solute carrier 15 (SLC15) family of proton-coupled oligopeptide transporters (POTs) in the brain, with a focus on Pept2 (Slc15A2) and PhT1 (Slc15A4). These transporters play a crucial role in the transport of di- and tripeptides, peptidomimetics, and drugs in the brain. The review highlights the pioneering work of David E. Smith in elucidating the impact of PepT2 at the choroid plexus and brain parenchymal cells, and discusses recent findings and future directions in brain POT research, including localization, regulatory pathways, transporter structure, species differences, and disease states.

PHARMACEUTICAL RESEARCH (2023)

Article Clinical Neurology

Blood-Brain Barrier Dysfunction in Normal Aging and Neurodegeneration: Mechanisms, Impact, and Treatments

Anuska V. Andjelkovic, Muyu Situ, Ali Francisco Citalan-Madrid, Svetlana M. Stamatovic, Jianming Xiang, Richard F. Keep

Summary: Cerebral endothelial cells and their tight junctions form the blood-brain barrier (BBB), which is a unique, dynamic, and multi-functional interface. This review focuses on the changes in BBB and the neurovascular unit in normal aging and neurodegenerative disorders, particularly Alzheimer's disease, cerebral amyloid angiopathy, and vascular dementia. Evidence suggests that BBB dysfunction contributes to neurodegeneration. The mechanisms underlying BBB dysfunction and its potential as a therapeutic target, including enhancing drug delivery, clearance of neurotoxic compounds, and preventing BBB dysfunction, are discussed. The need for novel biomarkers of BBB dysfunction is also addressed.

STROKE (2023)

Editorial Material Neurosciences

Retirement of Dr. Hazel Jones as Co-Editor-in-Chief of Fluids and Barriers of the CNS. Dr. Mark Hamilton becomes Co-Editor-in-Chief

Richard F. Keep, Lester R. Drewes

FLUIDS AND BARRIERS OF THE CNS (2023)

Editorial Material Neurosciences

A year in review: brain barriers and brain fluids research in 2022

Richard F. Keep, Hazel C. Jones, Mark G. Hamilton, Lester R. Drewes

Summary: The aim of this editorial is to highlight the advancements in brain barrier and brain fluid research in 2022. It encompasses studies on blood-brain, blood-retina, and blood-CSF barriers (choroid plexus and meninges), as well as the signaling within the neurovascular unit and elements of the brain fluid systems. Furthermore, it discusses the impact of brain barriers and brain fluid systems on CNS diseases, their role in disease progression, and the progress being made in treating such diseases.

FLUIDS AND BARRIERS OF THE CNS (2023)

Article Neurosciences

Epigenetics and stroke: role of DNA methylation and effect of aging on blood-brain barrier recovery

Chelsea M. Phillips, Svetlana M. Stamatovic, Richard F. Keep, Anuska V. Andjelkovic

Summary: This study examined the epigenetic and transcriptional profile of cerebral microvessels after stroke, revealing the role of DNA methylation in regulating blood-brain barrier (BBB) repair.

FLUIDS AND BARRIERS OF THE CNS (2023)

Editorial Material Neurosciences

Genetic disorders and genetic manipulation at the blood-brain barriers

Richard F. Keep, Hazel C. Jones, Lester R. Drewes

FLUIDS AND BARRIERS OF THE CNS (2023)

Review Clinical Neurology

Glymphatic system and post-hemorrhagic hydrocephalus

Fenghui Ye, Richard F. Keep, Ya Hua, Hugh J. L. Garton, Guohua Xi

Summary: This article discusses the role of the glymphatic system in posthemorrhagic brain injury, especially posthemorrhagic hydrocephalus.

BRAIN HEMORRHAGES (2023)

Article Neurosciences

Mechanisms of cerebrospinal fluid and brain interstitial fluid production

Jianming Xiang, Ya Hua, Guohua Xi, Richard F. Keep

Summary: This review evaluates the movement of fluid from blood to cerebrospinal fluid (CSF) and discusses the impact of ion transport in the choroid plexus (CP) epithelium and cerebral vasculature on fluid flow. It also addresses the potential targets for modulating CP fluid secretion, NKCC1 and TRPV4. Furthermore, it highlights the dynamic changes in fluid secretion and their role in the controversies over the CP's involvement in brain fluid secretion.

NEUROBIOLOGY OF DISEASE (2023)

Editorial Material Clinical Neurology

Deferoxamine Therapy for Hemorrhagic Transformation Following Brain Ischemia

Momodou G. Bah, Katherine G. Holste, Guohua Xi, Richard F. Keep

TRANSLATIONAL STROKE RESEARCH (2023)

Article Neurosciences

Spontaneously hypertensive rats can become hydrocephalic despite undisturbed secretion and drainage of cerebrospinal fluid

Sara Diana Lolansen, Dagne Barbuskaite, Fenghui Ye, Jianming Xiang, Richard F. Keep, Nanna MacAulay

Summary: This study elucidated the molecular mechanisms underlying the development of hydrocephalus in spontaneously hypertensive rats (SHRs), and found that it is not associated with elevated intracranial pressure (ICP) and does not require increased cerebrospinal fluid (CSF) secretion or inefficient CSF drainage. This type of hydrocephalus is not life-threatening and occurs due to unknown disturbances in CSF dynamics.

FLUIDS AND BARRIERS OF THE CNS (2023)

Article Biochemistry & Molecular Biology

Associations between liver function and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in non-demented adults: The CABLE study

Pei-Yang Gao, Ya-Nan Ou, Yi-Ming Huang, Zhi-Bo Wang, Yan Fu, Ya-Hui Ma, Qiong-Yao Li, Li-Yun Ma, Rui-Ping Cui, Yin-Chu Mi, Lan Tan, Jin-Tai Yu

Summary: Liver function may play a role in the progression of Alzheimer's disease. The study found that as AD progressed, certain liver function markers increased while others decreased. The relationship between liver function and CSF AD biomarkers indicates a potential mediation effect on cognition.

JOURNAL OF NEUROCHEMISTRY (2024)